2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phe nol (2E)-2-butenedioate (1:1)

We are 2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phe nol (2E)-2-butenedioate (1:1) CAS:380636-50-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phe nol (2E)-2-butenedioate (1:1)
CAS.NO:380636-50-0
Synonyms:2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phe nol (2E)-2-butenedioate (1:1)
(R)-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol hydrogen fumarate
 
Physical and Chemical Properties:
Molecular Formula C26H35NO6
Molecular Weight 457.55900
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fesoterodine Fumarate(CAS:286930-03-8).

2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phe nol (2E)-2-butenedioate (1:1)


Related News: Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.2-Bromo-6-chlorobenzaldehyde The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.2-metiltetrahidrofurano CAS:96-47-9 “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.[dimethyl-[3-(oxiran-2-ylmethoxy)propyl]silyl]oxy-dimethyl-[3-(oxiran-2-ylmethoxy)propyl]silane CAS:126-80-7 Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.

Related Products
Product Name
L-prolinamide View Details
carnosine View Details
3-Bromo-2-fluorotoluene View Details
2-[(Difluoromethyl)sulfonyl]pyridine Cas:1219454-89-3 manufacturer β-alanine manufacturer 4-Fluoro-3-methylphenol manufacturer 2-(2-Chlorophenyl)-4,5-diphenylimidazole manufacturer B,B’-2,8-Dibenzofurandiylbisboronic acid manufacturer